Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 4:1
Drug Approvals
5
NMPA:2
PHILIPPINES:2
SFDA:1
Drug Approvals
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字HJ20240162
- Approval Date
- Dec 6, 2024
NMPA
Azelastine Hydrochloride Eye Drops
- Product Name
- 盐酸氮䓬斯汀滴眼液
- Approval Number
- 国药准字HJ20230059
- Approval Date
- May 29, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 4
1 (50.0%)Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis
Phase 4
Completed
- Conditions
- BlepharitisSigns and Symptoms
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Ursapharm Arzneimittel GmbH
- Target Recruit Count
- 197
- Registration Number
- NCT01357538
- Locations
- 🇺🇦
Kharkov District Clinical Hospital, Kharkov, Ukraine
News
No news found